Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617.
Peng L, Hu Y, Mankowski MC, Ren P, Chen RE, Wei J, Zhao M, Li T, Tripler T, Ye L, Chow RD, Fang Z, Wu C, Dong MB, Cook M, Wang G, Clark P, Nelson B, Klein D, Sutton R, Diamond MS, Wilen CB, Xiong Y, Chen S.
Peng L, et al. Among authors: clark p.
Nat Commun. 2022 Mar 28;13(1):1638. doi: 10.1038/s41467-022-29288-3.
Nat Commun. 2022.
PMID: 35347138
Free PMC article.